What is the next best step for managing hypertension in an 85-year-old female patient already on 40 mg of lisinopril (angiotensin-converting enzyme inhibitor) and Lasix (furosemide, loop diuretic) daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Persistent Hypertension in an 85-Year-Old Female on Lisinopril and Furosemide

Add a dihydropyridine calcium channel blocker (amlodipine 2.5-5 mg daily) as the next step to achieve blood pressure control in this elderly patient already on maximal ACE inhibitor therapy and a diuretic. 1

Rationale for Adding a Calcium Channel Blocker

The combination of an ACE inhibitor (lisinopril), diuretic (furosemide), and calcium channel blocker represents the cornerstone triple therapy for resistant hypertension. 2

  • Amlodipine is particularly well-suited for elderly patients because it does not cause bradycardia and is generally well-tolerated in this age group 1
  • Start with amlodipine 2.5 mg daily and titrate gradually to minimize vasodilatory side effects such as peripheral edema 1
  • If blood pressure remains uncontrolled after 2-4 weeks, increase to amlodipine 5 mg daily 1

Target Blood Pressure Goals

  • For this 85-year-old patient, aim for a blood pressure goal of <140/90 mmHg if tolerated 1
  • While the general target for most adults is <130/80 mmHg, elderly patients require more cautious blood pressure reduction 3
  • Monitor for orthostatic hypotension by checking blood pressure in both sitting and standing positions, as elderly patients are at higher risk for postural drops 1

Alternative Fourth-Line Agent

If amlodipine is not tolerated or contraindicated, consider adding spironolactone as the fourth-line agent:

  • Spironolactone is the preferred fourth-line agent for resistant hypertension based on the PATHWAY-2 trial 2
  • Start with low doses (12.5-25 mg daily) in elderly patients 2
  • Monitor potassium levels closely, especially given concurrent ACE inhibitor use 4
  • Alternative agents include amiloride, doxazosin, or eplerenone if spironolactone is contraindicated 2

Important Monitoring Considerations

  • Recheck blood pressure within 4 weeks of adding amlodipine 1, 3
  • Target blood pressure control should be achieved within 3 months 3
  • Monitor serum electrolytes (particularly potassium), creatinine, and BUN frequently, especially in elderly patients on multiple antihypertensive agents 4
  • Ensure medication adherence, as pseudo-resistance due to non-adherence is common 2

Critical Pitfalls to Avoid

  • Do not discontinue the ACE inhibitor (lisinopril 40 mg) as it provides cardiovascular and renal protection beyond blood pressure control 5, 6
  • Avoid excessive blood pressure reduction that could compromise organ perfusion in elderly patients 1
  • Do not add a beta-blocker as the next agent in an elderly patient without specific cardiac indications, as they are less well-tolerated 1
  • Verify that the patient is actually taking medications as prescribed before escalating therapy 2
  • Confirm elevated blood pressure with home or ambulatory monitoring to exclude white coat hypertension 2

Dosing Considerations for Current Medications

  • The current lisinopril dose of 40 mg daily is at the maximum recommended dose for hypertension 6
  • Furosemide dosing appears appropriate, though the specific dose was not mentioned; typical dosing for hypertension is 40 mg twice daily 4
  • In elderly patients, furosemide should be used cautiously with careful monitoring of electrolytes and renal function 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.